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The objective of the study was to investigate the possible neuroprotective effect of ethanolic 
extract of Commiphora mukul gum resin (EtCMGR) against oxidative stress in the brain of 
streptozotocin (STZ) induced diabetic Wistar rats. The experimental animals were divided 
into four groups: control (C), control treated with EtCMGR (C+CM), diabetic (D) and diabet-
ic treated with EtCMGR (D+CM). Diabetes was induced by a single intraperitoneal injection 
of STZ (55 mg/kg body weight). Plant extract treated groups (C+CM and D+CM) were ad-
ministered EtCMGR at a dose of 200 mg/kg body weight/day by gavage for 60 days. Diabetic 
rats showed hyperglycemia, hypoinsulinemia with impaired insulin sensitivity. EtCMGR 
treatment to diabetic (D+CM group) rats prevented the rise in glucose level by 96.7 %, while 
enhancing insulin level (77.7 %) and improving insulin sensitivity (27.3 %) compared to D 
group. The brain antioxidant status of D group rats showed higher levels of lipid peroxidation 
(77.9 %), protein glycation (100 %), and increased activities of xanthine oxidase (47.1 %) and 
sorbitol dehydrogenase (101.9 %) and lowered concentration of reduced glutathione (38.2 %) 
and decreased activities of antioxidant enzymes i.e., glutathione reductase (24 %), glutathione 
peroxidase (24.4 %) and superoxide dismutase (42.1 %) and increased activities of catalase 
(87.4 %) and glutathione-S-transferase (45.3 %) compared to control group. While EtCMGR 
treatment for 60 days in D+CM group prevented the observed abnormalities of antioxidant 
status of D group. This study demonstrates that EtCMGR is a potent neuroprotective agent 
against oxidative damage induced under diabetes.  
 





Diabetes is characterized by hypergly-
cemia and metabolic abnormalities due to 
decreased insulin level/action, causing met-
abolic and physiological changes in various 
organs including brain (Genet et al., 2002). 
The brain was considered as an insulin-
insensitive tissue, however, recent molecu-
lar studies indicated that insulin is present 
in several regions of the central nervous 
system acting as a neuromodulator, inhibit-
ing food intake and stimulating fat oxida-
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tion (Zhao and Alkon, 2002). Hyperglyce-
mia is the most important factor responsible 
for the onset and progression of diabetic 
complication by producing oxidative stress 
(Giugliano et al., 1996). Diabetes also con-
tributes to cerebrovascular complication, 
reduction in cerebral blood flow, disturb-
ance of blood brain barrier and cerebral 
edema (Aragno et al., 1997). Cognitive def-
icits, along with morphological and neuro-
chemical alterations illustrate that the neu-
rological complications of diabetes are not 
limited to the peripheral neuropathies 
(Biessels et al., 1994). The neurological 
consequences of diabetes in the central 
nervous system are now receiving greater 
attention. Glucose uptake or utilization is 
decreased in the brain during diabetes 
providing a potential mechanism for in-
creased vulnerability to pathological events 
(McCall, 1992). Many studies showed hy-
perglycemia through excessive production 
of reactive oxygen species, glucose induced 
oxidative-nitrosative stress and increased 
operation of polyol pathway, which are crit-
ical pathogenic mechanisms that initiate a 
cascade of downstream metabolic and a 
neurovascular perturbation (Hounsom et al., 
2001). Concomitant with this new under-
standing of the injurious role of free radical 
oxidants in neuropathology, there is in-
creasing appreciation for the need of both 
fundamental and clinical research in the de-
velopment of the potential preventive and 
therapeutic benefits for a variety of antioxi-
dant nutritional and pharmacological inter-
ventions. Treatment strategies that focus on 
decreasing oxidative stress as well as en-
hancing antioxidant defense systems might 
present important options for the treatment 
of diabetic complications. Additionally, 
free radical scavengers have been shown to 
protect neurons against a variety of experi-
mental neurodegenerative conditions 
(Mosmann and Behl, 2002) as well as for 
attenuating the oxidative stress in STZ-
induced diabetes (Agustin et al., 1993; 
Montilla et al., 1998). Recently there has 
been a growing interest in anti-diabetic and 
antioxidant agents from natural products 
especially those derived from the plants, 
because plant sources are usually consid-
ered to be less toxic and more free from 
side effects than synthetic drugs.  
Commiphora mukul (C. mukul) belong-
ing to the family of Burseraceae, commonly 
known as guggul, a herbal resin of the C. 
mukul tree, also known as gum guggul or 
oleoresin, has been used in Indian ayurve-
dic medicine for centuries to treat a variety 
of ailments, including obesity, bone frac-
tures, arthritis, inflammation, cardiovascu-
lar diseases and lipid disorders (Satyavathi, 
1991; Sinal and Gonzalez, 2002; Urizar and 
Moore, 2003). Traditional uses of guggul 
include its anti-inflammatory, antispasmod-
ic, carminative, emmenagogue, hypogly-
cemic, alterative, antiseptic, astringent, a 
thyroid stimulant, anthelminitic and antihy-
perlipidemic properties. It also increases 
fibrinolytic activity and decreases platelet 
adhesiveness and scavenges free radicals in 
patients with atherosclerotic ischemic dis-
ease, thus reducing the cellular damage 
from ischemia (Sheela and Augusti, 1995; 
Gaur et al., 1997; Mary et al., 2003). Gug-
gulipid and ethyl extract of guggul are es-
tablished hypolipidemic agents in clinical 
practice. Guggul and guggulsterone were 
found to be effective antioxidants against 
LDL oxidation (Wang et al., 2004). Indeed 
several studies revealed cardio and neuronal 
protective activity of guggulsterone in ani-
mal models (Chander et al., 2003). Howev-
er, little is known about the possible attenu-
ating effect of EtCMGR on diabetic in-
duced oxidative stress in rat brain. In addi-
tion, our earlier studies proved hepatopro-
tective activity of C. mukul against oxida-
tive stress seen in insulin deficient (Bel-
lamkonda et al., 2011) and insulin resistant 
(Ramesh and Saralakumari, 2012) diabetic 
Wistar rats promoted us to design the pre-
sent study. Hence, our major goal is to 
characterize oxidative stress in the brain of 
STZ-induced diabetic rats and to evaluate 
the neuroprotective effect of EtCMGR 
against diabetic induced oxidative stress in 
the brain. 
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MATERIALS AND METHODS 
Chemicals 
The chemicals used in the current study 
were procured from Sigma Chemical Com-
pany (St. Louis, MO, USA), and SISCO 




Ethanolic extract of C. mukul gum resin 
(brown, dry powder with lot No. 
L6211038) was obtained from the manufac-
turers and exporters of herbal extracts, 
Plantex Pvt. Ltd., Vijayawada, Andhra Pra-
desh, India. The procedure followed by the 
firm for the preparation of extract is as fol-
lows: The plant was identified by Dr. K. 
Narasimha Reddy, taxonomist, Laila impex 
R and D Center, Vijayawada. The collected 
plant sample (resin) was washed thoroughly 
with tap water, dried at room temperature 
away from sun light, cut into small pieces 
and then powdered. Ethanolic extract was 
prepared by cold maceration of gum resin 
powder in ethanol for 7 days. The extract 
was filtered, concentrated under reduced 
pressure and finally dried in a vacuum des-
iccator. Herb to product ratio was 8:1. A 
voucher specimen has been deposited in the 
Department of Biochemistry, Sri Krish-
nadevaraya University, Anantapur, under 
number DSK-CM-2010. The extract was 
stored at 0–4 °C. The extract was suspend-
ed in 5 % Tween-80 in distilled water prior 
to use. 
 
Induction of diabetes mellitus 
Male Wistar rats of 2-3 month old 
weighing (125-150 g) were procured from 
Sri Venkateswara enterprises (Bangalore, 
India). They were acclimatized for 7 days 
in our animal house (Regd. No. 
470/01/a/CPCSEA, dt. 24th Aug, 2001) and 
maintained under standard conditions of 
temperature and relative humidity with 12 h 
light/dark cycles. Diabetes was induced in 
overnight fasted rats by a single intraperito-
neal injection of freshly prepared STZ 
(55 mg/kg body weight) in 0.05 M ice-cold 
citrate buffer (pH 4.5) in a volume of 0.1 ml 
per rat. After 72 hours of STZ administra-
tion, the plasma glucose level of each rat 
was determined for confirmation of diabetic 
induction. Rats with plasma glucose level 
above 230 mg/dL were considered as dia-
betic and used subsequently. 
 
Experimental design 
In the present experiment, a total of 32 
rats (16 control and 16 diabetic surviving 
rats) were used. The rats were divided into 
four groups of eight each: control (C); con-
trol treated with EtCMGR (C+CM); diabet-
ic (D); diabetic treated EtCMGR (D+CM). 
The dose of EtCMGR in the current study 
is based on the earlier reports on the extract 
(Panda and Kar, 1999). The extract was 
administered through oral intubation to 
C+CM and D+CM groups at a dose of 
200 mg/kg body weight per day for 60 
days. 
Initially (0 day) and at the end of exper-
imental period (60 days), blood was col-
lected from 12 h fasted rats with capillary 
tube from retro-orbital sinus from experi-
mental animals into fresh vials containing 
EDTA (10 mg/ml) as anti-coagulant. The 
plasma obtained after centrifugation was 
used for glucose and insulin assay. Plasma 
glucose level was estimated by glucose ox-
idase-peroxidase enzymatic method using 
span diagnostic kit as per the manufacturers 
instructions and plasma insulin level was 
estimated by radioimmuno assay method 
(Bhabha Atomic Research Centre, Mum-
bai). Homeostasis Model Assessment 
(HOMA), used as an index to measure the 
degree of insulin resistance (IR), was calcu-
lated by the formula: fasting plasma insulin 
(µU/ml) × fasting glucose (mmol/L) / 22.5 
(Pickavance et al., 1999).  
 
Animal sacrifice and organ collection 
After the experimental period of 60 
days, the animals from each experimental 
group were starved for 12 h and sacrificed 
by cervical dislocation and immediately the 
whole brain was dissected out and washed 
with ice-cold saline and used for analysis. 
Ten percent homogenate of brain was pre-
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pared by using Potter-elvehjem homogeniz-
er with Teflon pestle at a 4 °C in 0.15 M 
KCl. The whole homogenate was used for 
estimation of reduced glutathione (GSH) 
and lipid peroxidation (LPO). The homoge-
nate was centrifuged in cooling centrifuge 
(12000 rpm for 45 min at 0-4 oC) to remove 
the debris and supernatant was used for en-
zyme assays. The total protein content of 
the brain in the whole homogenate was es-
timated by the method of Lowry et al. 
(1951). 
 
Estimation of lipid peroxidation 
Lipid peroxidation in brain was estimat-
ed colorimetrically by measuring the thio-
barbituric acid reactive substances 
(TBARS) by the method of Utley et al. 
(1967). To 0.1 ml of 10 % tissue homoge-
nate, 2 ml of 10 % TCA and 4 ml of 0.67 % 
TBA were added and heated in a water bath 
for 30 min and cooled. Absorbance of the 
supernatant was read at 535 nm. The extent 
of LPO was expressed as nmoles of 
malondialdehyde (MDA) formed/g tissue, 
using a molar extinction co-efficient of 
MDA as 1.56 ҳ 105 M-1 cm-1. 
 
Estimation of reduced glutathione 
Reduced glutathione was estimated in 
brain homogenate (10 %) using a disulfide 
compound, 5,5’-dithio-bis-nitrobenzoic ac-
id (DTNB), which readily gets reduced by 
sulfhydryl compounds forming a highly 
colored anion having maximum absorbance 
at 412 nm, as outlined by the method of 
Ellman’s (1959). 
 
Estimation of protein glycation 
Protein glycation in brain was measured 
by quantification of amadori product via 
Borohydride-Periodate assay as modified 
by Zhang and Swann (1999). 
 
Assay of enzymes in brain homogenate 
Sorbitol dehydrogenase 
Sorbitol dehydrogenase (SDH) activity 
was measured by the method of Gerlach 
and Hiby as described by Bergmeyer and 
Bernt (1974). To 1.6 ml of triethanolamine 
(107 mM, pH 7.4), 0.1 ml of NADH 
(0.4 mM) and 0.1 ml of supernatant of brain 
homogenate were added and incubated at 
25 0C for 30 min. The reaction was initiated 
by the addition of 0.3 ml of fructose (4 M). 
Decrease in absorbance was monitored at 1 
min interval for 5 min at 340 nm. The activ-
ity was expressed as nmoles of NADH oxi-
dized/min/mg protein by using millimolar 
extinction coefficient of NADH as 6.22. 
 
Xanthine oxidase 
Xanthine oxidase (XO) catalyses the 
oxidation of xanthine to uric acid. The ac-
tivity of enzyme in brain was assayed by 
the increase in uric acid concentration by 
the method of Roussos (1967). Briefly, the 
assay mixture consists of 0.3 ml of Tris-
HCl buffer (50 mM, pH 7.4), 0.3 ml of 
CuSO4 (10 mM), 0.05 ml of xanthine 
(2.6 mM in 0.05 M glycine buffer, pH 7.4) 
and 0.25 ml of distilled water. The reaction 
was initiated by the addition of 0.05 ml of 
brain homogenate and increase in absorb-
ance was monitored at 290 nm at 15 sec 
interval for 2 min. The activity was calcu-
lated by using a molar extinction co-
efficient of uric acid as 1.22. 
 
Glutathione reductase 
Glutathione reductase (GR) catalyses 
the reduction of oxidized glutathione 
(GSSG) by NADPH to GSH. The activity 
of GR in brain was measured by the method 
of Pinto and Bartley (1969). In brief, the 
assay mixture consists of 0.5 ml of phos-
phate buffer (0.25 M, pH 7.4), 1.0 ml of 
EDTA (25 mM), 0.1 ml of NADPH 
(1 mM), 0.96 ml of distilled water and 
0.1 ml of brain homogenate. The reaction 
was initiated by the addition of 0.024 ml of 
GSSG (50 mM). The activity was expressed 
as µmoles of NADPH oxidized/min/mg 
protein by using millimolar extinction coef-
ficient of NADPH as 6.22. 
 
Glutathione peroxidase 
Glutathione peroxidase (GPx) in brain 
was measured by the method of Rotruck et 
al. (1973). Briefly, the reaction mixture 
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consists of 0.5 ml of phosphate buffer 
(0.2 M, pH 7.0 containing 0.4 mM EDTA, 
and 10 mM sodium azide), 0.2 ml of brain 
homogenate, 0.2 ml of GSH (2 mM) and 
0.1 ml of H2O2 (0.2 mM) and incubated for 
10 min at room temperature along with 
blank containing all reagents expect tissue 
homogenate. The reaction was arrested by 
the addition of 0.5 ml of TCA (10 %), cen-
trifuged at 4000 rpm for 5 min and GSH 
content in 0.5 ml of supernatant was esti-
mated by following the method of Ellman’s 
(1959). The activity was expressed as µg of 
GSH consumed/min/mg protein. 
 
Glutathione-S-transferase 
Glutathione-S-transferase (GST) in 
brain was measured by the method of Habig 
et al. (1974). The assay mixture consists of 
1.7 ml of sodium phosphate buffer (0.14 M, 
pH 6.5), 0.2 ml of GSH (30 mM) and 
0.04 ml of homogenate. The reaction was 
initiated by addition of 0.06 ml of 1-chloro-
2,4-dinitrobenzene (CDNB) (0.01 M, dis-
solved in 50 % ethanol). The activity was 
calculated by using millimolar extinction 
co-efficient of CDNB-GSH conjugate as 
9.6. The activity was expressed as µmoles 




Catalase (CAT) activity was assayed by 
the method of Beers and Sizer (1952). The 
assay mixture consists of 1.9 ml of sodium 
phosphate buffer (0.05 M, pH 7.0), 1.0 ml 
of H2O2 (0.059 M) and 0.1 ml of brain ho-
mogenate. The activity was expressed as 




Superoxide dismutase (SOD) activity in 
brain was determined according to a modi-
fied procedure adopted by Soon and Tan 
(2000). Superoxide dismutase activity was 
measured based on the ability of the en-
zyme to inhibit the oxidation of pyrogallol. 
The assay mixture consists of 0.5 ml of 
phosphate buffer (50 mM, pH 7.8 contain-
ing 1 mM EDTA), 0.02 ml of brain homo-
genate and 0.86 ml of distilled water. The 
reaction was initiated by the addition of 
0.02 ml of pyrogallol (10 mM, in 0.01 N 
HCl). One unit of SOD was defined as the 
amount of enzyme required to inhibit the 
oxidation of pyrogallol by 50 % in standard 
assay system of 3 ml. The activity was ex-
pressed as Units/min/mg of protein. 
 
RESULTS 
General observation and characteristics 
No visible side effects and variations in 
animal behavior (respiratory distress, ab-
normal locomotion and cathelepsy) were 
observed in C+CM group of rats, indicating 
the non-toxic nature of C. mukul admin-
istration. 
 
Body weight, fasting plasma glucose, insu-
lin and HOMA 
Table 1 represents body weight, fasting 
plasma glucose and insulin and HOMA 
values of four experimental groups at 0 (ini-
tial) and 60 (final) days of experimental pe-
riod. Characteristic symptoms of diabetes 
such as polyphagia, polydipsia, polyuria 
and loss of body weight observed in the D 
group were rectified in D+CM group. 
Groups D and D+CM showed a slight but 
significantly lesser initial body weight 
compared to C and C+CM groups. During 
the experimental period, D group showed a 
decrease in the body weight whereas C, 
C+CM and D+CM groups showed a trend 
of increase in body weight. At the end of 
the experimental period, D group showed 
(20 %) reduction in body weight while C, 
C+CM and D+CM groups showed an in-
crease in the body weight by 54 %, 50 %, 
and 29 % respectively. By the end of the 
experimental period, the body weight of 
D+CM group was 25 % lower than C group 
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Table 1: Effect of EtCMGR on body weight, fasting plasma glucose, insulin level and HOMA values in 
















Initial (0 day) 182.5 ± 1.99a 74.5 ± 1.10a 42.0 ± 0.65a 7.7 ± 0.16a 
Final (60 day) 282.0 ± 1.99e 76.8 ± 1.59a 46.0 ± 1.25a 8.7 ± 0.30b 
 
C+CM 
Initial (0 day) 184.3 ± 2.31a 75.1 ± 0.91a 41.1 ± 0.39a 7.6 ± 0.18a 
Final (60 day) 276.5 ± 1.47e 74.3 ± 1.32a 44.7 ± 1.22a 8.2 ± 0.32b 
 
D 
Initial (0 day) 168.9 ± 1.87b 388.3 ± 4.63c 12.3 ± 1.06b 11.8 ± 0.44c 
Final (60 day) 134.6 ± 1.63c 425.2 ± 3.72d 1.6 ± 0.65b 12.2 ± 0.73c 
 
D+CM 
Initial (0 day) 166.2 ± 1.33b 397.6 ± 4.69c 12.8 ± 0.51b 12.6 ± 0.44c 
Final (60 day) 214.6 ± 2.45d 95.3 ± 1.48b 29.3 ± 0.93c 6.9 ± 0.18d 
Values are expressed as mean ± S.E.M (n=8). Means with different superscripts within the column are significant-
ly different at P<0.05 (Duncan’s multiple range test). 
C: control, C+CM: control treated with Commiphora mukul, D: diabetic, D+CM: diabetic treated with Commiphora 
mukul, HOMA: Homeostasis Model Assessment, EtCMGR: ethanolic extract of Commiphora mukul gum resin 
 
 
At 0 days, plasma glucose levels of D 
and D+CM groups were significantly high-
er than corresponding value of C group. 
This indicates the induction of hyperglyce-
mia in D and D+CM groups. Plasma glu-
cose level of C group and C+CM group rats 
at 60 days were not deviated from their cor-
responding initial values. Group D rats 
showed 10 % increase in plasma glucose 
level at 60 days compared to its initial val-
ue. A significant antihyperglycemic effect 
of EtCMGR administration was evident in 
D+CM group by 76 % reduction in the 
plasma glucose level at 60 days compared 
to initial day and bringing the value to near 
control level. 
The initial fasting plasma insulin levels 
of D and D+CM groups were around 4-fold 
lower than C and C+CM groups. By the end 
of the experimental period, plasma insulin 
levels showed no variation in C and C+CM 
groups and 5.7 % decrease in D group and 
129 % increase in D+CM group compared 
to their respective initial values. Thus, at 
the end of the experimentation, the plasma 
insulin level of D+CM group was 152 % 
higher than D group, but still 36 % lower 
than C group. 
HOMA approach has been widely used 
in clinical research to assess insulin sensi-
tivity. There was no deviation in the initial 
HOMA values between C and C+CM 
groups. Significantly higher initial HOMA 
values were observed in D and D+CM 
groups compared to C group. At the end of 
the experimental period, C and C+CM 
groups showed 13 % and 7.9 % increase in 
their HOMA values when compared to their 
respective initial values. HOMA value of D 
group at 60 days was significantly higher 
than C and C+CM groups with no signifi-
cant variation from its initial HOMA value, 
whereas D+CM group showed 45.1 % de-
crease in its HOMA value compared to its 
initial value. Thus, by the end of experi-
mentation, the HOMA value of D+CM 
group was significantly lower than the re-
maining three groups. 
 
Brain oxidative stress markers and anti-
oxidants 
Table 2 illustrates the levels of markers 
of oxidative stress viz. GSH, LPO, protein 
glycation, and activities of XO and SDH in 
the brain of four experimental groups. 
Group D showed depleted brain GSH levels 
(38 %) as compared to C group but treat-
ment with EtCMGR (D+CM) limited the 
depletion to 26 % only. C+CM group 
showed no variation in the levels of oxida-
tive stress markers from C group. Group D 
showed significantly higher levels of LPO 
(78 %), protein glycation (101 %), XO 
(47 %) and SDH (34 %) as compared to C-
group. D+CM group showed significantly 
lower LPO (29 %), protein glycation 
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(34 %), and decreased activities of XO 
(19 %) and SDH (46 %), when compared 
with D group but they are still significantly 
higher than C group (26 %, 32 %, 9.5 % 
and 20 % respectively). 
Table 3 indicates the activities of anti-
oxidant enzymes in the brain of four exper-
imental groups. Group D showed signifi-
cantly higher activities of GST (45 %) and 
CAT (87 %) and significantly lower activi-
ties of GR (24 %), GPx (24 %) and SOD 
(42 %) as compared to C group. Group 
D+CM showed significantly lower activi-
ties of GST (21 %) and CAT (21 %) and 
significantly higher activities of GR (25 %), 
GPx (13 %) and SOD (45 %), when com-
pared with D group. 
 
 
Table 2: Effect of EtCMGR administration on brain oxidative stress markers in streptozotocin-induced 
diabetic rats 
Experimental groups C C+CM D D+CM 
Reduced glutathione 
(µg/mg protein) 7.41 ± 0.58
c 7.99 ± 0.34c,a 4.58 ± 0.70a 5.52 ± 0.34a 
Lipid peroxidation 
(nmols of MDA/mg  
protein) 
0.190 ± 0.022a 0.164 ± 0.009a 0.338 ± 0.021b 0.240 ± 0.018a 
Protein glycation (nmols 
of fructose/mg protein) 30.86 ± 0.47
a 34.25 ± 0.61b 62.01 ± 1.35d 40.79 ± 1.07c 
Xanthine oxidase 
(µmoles of NADH 
formed/min/mg protein) 
24.52 ± 1.27a 19.28 ± 1.33b 36.07 ± 1.36d 29.33 ± 1.09c 
Sorbitol dehydrogenase 
(nmols of NADH con-
sumed/min/mg protein) 
0.106 ± 0.010a 0.134 ± 0.004a 0.214 ± 0.011b 0.116 ± 0.006a 
Values are expressed as mean ± S.E.M (n=8). Means with different superscripts within the row are significantly 
different at P<0.05 (Duncan’s multiple range test). C: control, C+CM: control treated with Commiphora mukul, D: 




Table 3: Effect of EtCMGR administration on the activities of antioxidant enzymes in the brain of 
streptozotocin-induced diabetic rat 
Experimental groups C C+CM D D+CM 
Glutathione reductase 
(µmols of NADPH oxidized/ 
min/mg protein) 
31.41 ± 1.65a 32.88 ± 1.17a 23.88 ± 0.75b 29.94 ± 0.66a 
Glutathione peroxidase 
(µg of GSH consumed/min/ 
mg protein) 
12.27 ± 0.29c 12.10 ± 0.33c 9.28 ± 0.36a 10.45 ± 0.25b 
Glutathione-S-transferase 
(µmols of GSH-CDNB  
conjugate formed/min/ 
mg protein) 
0.150 ± 0.007a 0.158 ± 0.005a 0.218 ± 0.009b 0.172 ± 0.009a 
Superoxide dismutase 
(U/min/mg protein) 8.97 ± 0.07
d 8.70 ± 0.23b 5.19 ± 0.13a 7.53 ± 0.19c 
Catalase (mmols of H2O2  
decomposed/min/mg   
protein) 
2.62 ± 0.24c 1.88 ± 0.14d 4.91 ± 0.20a 3.8 ± 0.19b 
Values are expressed as mean ± S.E.M (n=8). Means with different superscripts within the row are significantly 
different at P<0.05 (Duncan’s multiple range test). C: control, C+CM: control treated with Commiphora mukul, D: 
diabetic, D+CM: diabetic treated with Commiphora mukul, EtCMGR: ethanolic extract of Commiphora mukul gum 
resin 
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The results were expressed as mean ± 
S.E.M. Data were analyzed for significant 
difference using Duncan’s Multiple Range 
(DMR) test (P < 0.05) (Duncan, 1955). 
 
DISCUSSION 
Streptozotocin induced hyperglycemia 
in rodents is considered to be a good model 
for diabetes mellitus with insulin deficiency 
condition and a relevant example of endo-
genous chronic oxidative stress. The devel-
opment of hyperglycemia in rats following 
STZ injection is primarily due to direct 
pancreatic β-cell dysfunction. STZ [(2-
deoxy-2-(3-(methyl-3-nitrosoureido)-D-glu-
copyranose)] is a potent DNA methylating 
agent and acts as a donor of nitric oxide in 
pancreatic cells. β-cells are particularly sen-
sitive to damage by nitric oxide and free 
radicals because of their low levels of anti-
oxidant potential (Spinas, 1999). Further it 
causes DNA strand breaks in pancreatic is-
lets stimulating nuclear poly (ADP-ribose) 
synthetase and thus depleting the intracellu-
lar NAD+ levels, which in turn inhibits pro-
insulin synthesis and induces diabetes (Wil-
son et al., 1988). In the present study, 
treatment with EtCMGR showed significant 
antihyperglycemic activity in D+CM group 
rats. The antihyperglycemic activity of this 
plant may be, at least in part, through re-
lease of insulin from the pancreas in the 
view of measured plasma insulin concentra-
tion and increased insulin sensitivity as an 
evident by decreased HOMA values in 
D+CM group rats compared to D group. 
The significant increase in plasma insu-
lin levels of D+CM group compared to D 
group may be attributed to the regeneration 
the STZ-destructed β-cells which is proba-
bly due to the fact that pancreas contains 
stable (quiescent) cells that have the capaci-
ty to regenerate (Banerjee et al., 2005; Cano 
et al., 2008). Therefore, the surviving cells 
can proliferate to replace the lost cells. Phy-
tochemicals such as flavonoids and alka-
loids present in the EtCMGR may have pro-
tected the intact functional β-cells from fur-
ther deterioration through oxidative stress. 
Hence, β-cells remain active and continue 
to produce insulin. It is also claimed that 
antioxidants such as flavonoids are possibly 
beneficial in preventing STZ-induced dia-
betes by stopping oxidative damage of the 
pancreas, and increasing insulin secretion 
by the regeneration of pancreatic β-cells 
(Bravi et al., 2006). 
The observed significant increase in the 
HOMA values by the end of experimental 
period in C and C+CM groups indicates a 
gradual progression of insulin resistance 
with aging. However, this increase is less in 
C+CM group compared to C group indicat-
ing the protective effect of C. mukul against 
progression of insulin resistance with aging. 
Significantly higher initial and final HOMA 
values of D group compared to correspond-
ing values of C group indicate existence of 
decreased insulin sensitivity in STZ-
induced diabetic rats in addition to insulin 
deficiency. Insulin sensitizing activity of C. 
mukul is further evident from the decreased 
final HOMA values of D+CM group com-
pared to its initial as well as remaining 
group’s final HOMA values. 
Our earlier studies demonstrated the ex-
istence of oxidative stress in liver (Bellam-
konda et al., 2011), kidney (Rasineni et al., 
2010), pancreas and heart (Ramesh et al., 
2012) in STZ-induced diabetic rats and in 
erythrocytes and reticulocytes of diabetic 
patients (Sailaja et al., 2003). In agreement 
with earlier reports (Montilla et al., 1998), 
the present study demonstrates that STZ-
induced diabetes mellitus causes oxidative 
stress in the brain. The present study is the 
first to show the neuroprotective effect of 
C. mukul against diabetes induced altera-
tions in the brain of rats.  
Streptozotocin induced diabetes serves 
as an excellent model to study the cellular, 
biochemical, molecular and morphological 
changes in brain induced by stress during 
diabetes (Aragno et al., 2000). Hypergly-
cemia is the most important factor in the 
onset and progress of diabetic complica-
tions mainly by producing oxidative stress. 
Hyperglycemia induced tissue damage fa-
vours some particular subset of cell types, 
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which are involved in diabetic complication 
(capillary endothelial cells of retina, 
mesangial cells of glomerulus, neurons and 
Schwann cells in peripheral nerves) due to 
the fact that most cells are able to reduce 
the transport of glucose inside the cell when 
they are exposed to hyperglycemia, so that 
internal glucose concentration remains con-
stant. Brain is an insulin independent tissue 
and leads to high exposure to glucose under 
hyperglycemic conditions. Cerebral glucose 
increased after the onset of diabetes in rats 
(Nayeemunnisa, 2009). This increased in-
tracellular glucose load leads to auto-
oxidation of glucose, generation of free rad-
icals, enhanced lipid peroxidation and non-
enzymic glycation proteins, increased poly-
ol pathway. The central nervous system is 
highly susceptible to oxidative stress. Vul-
nerability of brain to oxidative stress in-
duced by oxygen free radicals seems to be 
due to the fact that on one hand, the brain 
utilizes about one fifth of total oxygen de-
mand of body and on other because of its 
relatively small antioxidant capacity. Fur-
ther, the brain contains relatively high con-
centration of easily peroxidiable fatty acids 
(Carney et al., 1991) and it is known that 
certain regions of brain are highly enriched 
in iron, a metal that in its free form is cata-
lytically involved in production of damag-
ing oxygen free radical species. Antioxidant 
therapy is proved to be remarkably benefi-
cial to combat reactive oxygen species in-
duced injury in CNS. Our results showed 
that lipid peroxidative damage of the brain 
increased in D group of rats. This is associ-
ated with significant increase in brain pro-
tein glycation and enhanced activities of 
sorbitol dehydrogenase and xanthine oxi-
dase in diabetic rats. Lipid peroxidation is a 
free radical related process which is poten-
tially harmful because its uncontrolled self 
enhancing process causes disruption of 
membranes, lipids and other cell compo-
nents. Reactive oxygen species can increase 
the permeability of blood brain barrier and 
inhibits the mitochondrial respiration lead-
ing to geometrical progression of lipid per-
oxidation (Gilman et al., 1993). Our reports 
of increase in extent of lipid peroxidation in 
the brain of diabetic rats are in agreement 
with earlier studies (Kumar and Menon, 
1993; Pari and Murugan, 2007; Rastogi et 
al., 2008) suggesting that the increased lipid 
peroxidation plays a major role in the de-
velopment of enhanced oxidative stress. 
One of the consequences of chronic hy-
perglycemia is the excessive non-enzymic 
glycation of proteins known as Millard re-
action and leads to alter protein confirma-
tion and function and decreased its half life 
period, resulting in complication of diabe-
tes. Enhanced glycated protein concentra-
tion observed in the brain of D group of rats 
may induce the formation of oxygen de-
rived free radicals contributing to enhance-
ment of oxidative stress. Our report of in-
crease in extent of protein glycation in dia-
betic rat brain is in consistence with previ-
ous reports in literature (Brownlee et al., 
1988; Das Evcimen et al., 2004). In addi-
tion, the enhanced protein glycation in D 
group rats may also be due to increased op-
eration of polyol pathway as reflected by 
increased activity of sorbitol dehydrogenase 
in diabetic rat, thus leading to the increased 
production of sorbitol and fructose. Under 
hyperglycemic conditions, high glucose 
flux through sorbitol pathway accounts for 
one third of glucose metabolism (Gonzalez 
et al., 1984). This has important implication 
in terms of redox changes of NADP+ and 
NAD+ couples and metabolism of glucose 
by alterative pathways (Jeffrey and Jorn-
vall, 1983). Conversion of glucose to sorbi-
tol by aldose reductase requires NADPH 
and forms NADP+ thereby competing with 
other NADPH requiring reactions. Conver-
sion of sorbitol to fructose by sorbitol de-
hydrogenase is coupled to the reduction of 
NAD+ to NADH and this competes with 
glycolysis at the glyceraldehyde dehydro-
genase step for NAD+ (Gonzalez et al., 
1986). It reduces the proportion of NADPH 
by NAD+ and increases the proportion of 
NADH by NAD+. The trouble in the oxida-
tion of NADH in the respiratory chain is 
indicated as hyperglycemia “pseudohypox-
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ia” and leads to increasing the quantity of 
reactive oxygen species in the cells. 
Further increased activity of XO, an 
important source of oxygen free radicals in 
the brain of D group rats may contribute to 
the free radical mediated damage and de-
velopment of diabetic complication of 
brain. Xanthine oxidoreductase under nor-
mal condition exists in dehydrogenase form 
and uses NAD+ and there is very little pro-
duction of superoxide anions. Under NAD+ 
deficient and/or ischemic condition, there is 
depletion of ATP leading to subsequent loss 
of membrane Ca2+ gradient. Increased cal-
cium levels activate Ca2+ dependent prote-
ases which cause selective proteolysis of 
the dehydrogenases to convert it into xan-
thine oxidase which acts both on hypoxan-
thine and xanthine at the expense of molec-
ular oxygen to produce superoxide ions. 
Increased activity of XO in the diabetic rats 
in the present study is in agreement with 
earlier studies in rat brain (Ates et al., 
2007). 
Reduced glutathione is a major endoge-
nous antioxidant which counter balances 
free radical mediated damage (Mazumder et 
al., 2005). It is well known that GSH is in-
volved in the protection of normal cell 
structure and function by maintaining the 
redox homeostasis, quenching free radicals 
and by participating in detoxification reac-
tions (Matcovis et al., 1982). A significant 
decrease in the level of GSH observed in 
the brain of D group rats compared to C 
group rats could be the result of decreased 
synthesis or increased degradation/utili-
zation of GSH by increased oxidative 
stress. The decreased GR activity, the en-
zyme responsible for regeneration of GSH 
from GSSG may also contribute to the ob-
served depleted levels of GSH in the brain 
of D group rats. The significant decrease in 
GR activity in the brain of D group rats 
may be due to less availability of NADPH, 
the cofactor required for this enzyme be-
cause diversion of NADPH by enhanced 
operation of polyol pathway as reflected by 
significantly increased activity of SDH in D 
group rats. Besides, the reported reduced 
ATP levels (Mastrocola et al., 2005) as a 
result of change in the activities of mito-
chondrial respiratory chain enzymes in the 
brain of diabetic rats are also closely related 
to the decreased de novo synthesis of GSH. 
Our reports of decreased GSH and GR ac-
tivity in D group rats were supported by 
earlier studies (Montilla et al., 2005; Pari 
and Murugan, 2007) suggesting that the de-
creased GSH are sensitive and potentially 
relevant indicators of neurotoxicity and 
play a role in the development of diabetic 
complications in brain. Superoxide dis-
mutase protects the cell against the toxic 
effect of superoxide radicals by converting 
it to less toxic H2O2. Glutathione peroxi-
dase is responsible both for metabolizing 
lipid peroxides and for the decomposes of 
H2O2. The significant decrease in the activi-
ties of SOD and GPx in the brain of D 
group rats compared to C group rats im-
plied weak antioxidant status through these 
enzyme activities. The increase in activity 
of XO in D group is important since XO is 
recognized as one of the extra mitochondri-
al sites of superoxide generation. This prob-
lem gets further aggravated by the de-
creased activity of SOD in diabetic rats. 
The depletion in GSH level of D group rats 
may be responsible for the decreased activi-
ty of GPx since GSH is the substrate for the 
GPx activity. However, surprisingly there 
was an increased CAT and GST activities 
in diabetic rat brain compared to control in 
the study. A survey of literature revealed 
that activities of antioxidant enzymes varied 
in the different organs and different diabetic 
phases (Huang et al., 2006). Glutathione-S-
transferase is a multifunctional protein 
found in many tissues and shows a broad 
specificity for organic hydroperoxides but 
not for H2O2 (Freeman and Crapo, 1982) 
and it has an important role in the central 
nervous system including a line of defense 
in astrocytes against potentially toxic xeno-
biotics and in protecting the myelin sheath 
(Cooper and Meister, 1993). Our reports of 
increased GST in diabetic rats suggest en-
hanced utilization of GSH for detoxification 
of toxic products. Increased CAT activity 
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decomposes H2O2 without generation of 
free radicals by minimizing one electron 
transfer (Corrocher et al., 1986; Mueller et 
al., 1997) of diabetic rat which indicates a 
compensatory adaptive mechanism against 
oxidative stress to maintain homeostasis. 
However, enhanced activities of CAT and 
GST are not sufficient to overcome the oxi-
dative stress as reflected by enhanced oxi-
dative stress markers in the present study. 
Antioxidant potential of C. mukul 
against oxidative stress is evident with low-
er levels of LPO, protein glycation, activi-
ties of XO and SDH, higher levels of GSH 
and increased activities of antioxidant en-
zymes as seen in the brain of D+CM group 
when compared with D group. The antioxi-
dant potential of this plant was well docu-
mented in literature (Bellamkonda et al., 
2011; Ramesh and Saralakumari, 2012). 
The antihyperglycemic effect with in-
creased insulin sensitivity of C. mukul is 
evident from the decreased plasma glucose 
level of D+CM group which further result-
ed in decreased flux of glucose through 
polyol pathway by decreasing the SDH ac-
tivity indicating a consequent increase in 
the ratio of NADPH/NADP+. Thus in-
creased availability of NADPH may be re-
sponsible for increased GR activity, restor-
ing it to control values in D+CM group rats. 
This in turn elevates the availability of 
GSH, the substrate for GPx, resulting in 
increased activity of GPx, which further 
scavenges lipid peroxides, hydrogen perox-
ides and hydroxyl radicals resulting in nor-
malization of LPO in D+CM group. Fur-
ther, the significant increase in the activity 
of SOD of D+CM rats compared to D 
group rats bringing it to near control values 
reflects the protection against superoxide 
radicals and thus oxidative stress. The im-
balance in the activities of antioxidant en-
zymes in the D group of rats as reflected by 
enhanced activities of CAT and GST was 
corrected by restoring these enzyme activi-
ties to near control and control values re-
spectively in D+CM group. Earlier studies 
showed wild type diabetic mice are suscep-
tible to develop diabetic neuropathy by re-
duced nerve conduction velocity, structural 
abnormalities in the nervous tissue (Ya-
gihashi et al., 2001) with decreased GSH 
level in their sciatic nerve whereas Chung 
et al. ( 2003) reported that polyol pathway 
was the major source of diabetes induced 
oxidative stress from their observation of no 
change in GSH levels with unaltered nerve 
conduction velocity in aldose reductase 
gene knockout diabetic mice. The entire 
process of antioxidant potential of C. mukul 
can be explained by a mechanism whereby 
decreased flux through the polyol pathway 
increases the effectiveness of GSH redox 
cycle in scavenging free radicals in addition 
to “C. mukul” antihyperglycemic, insulino-
genic and enhanced insulin sensitizing ac-
tivities. 
Till date, several chemical components 
such as diterpenes, sterols, steroids, esters 
and higher alcohols have been identified in 
C. mukul (Zhu et al., 2001; Wang et al., 
2004). Oleoresin of C. mukul is a mixture of 
several steroid lipids. Of these steroids, Z-
guggulsterone and E-guggulsterone are the 
most effective (Patil et al., 1972; Sukh, 
1987). Guggulsterones in the body are easi-
ly reduced to guggulsterols which behave as 
powerful antioxidants. The antioxidant 
properties of guggulsterols could be ex-
plained by the fact that their hydroxyl 
groups are present at α-positions of double 
bonds, similar to antioxidant vitamins, and 
are soluble in lipids. The steroid structure 
also contains H, CH3 and O bond, which 
indicates that the drug, like other herbs may 
also quench free radicals such as hydroxyl 
and singlet oxygen due to its antioxidant 
effect thus causing a decrease in lipid per-
oxides similar to the action of probucol 
(Anderson et al., 1991). The guggulsterols, 
appear to be non-toxic, because they have 
no highly reactive groups in any position of 
the isomer structure, similar to tocopherols. 
Guggulipid, the resin of C. mukul was re-
ported to decline LPO in hypercholester-
olemic humans (Singh et al., 1994) and 
Cu+2 mediated oxidative stress (Chander et 
al., 2003). Guggulipid and guggulsterone 
have been demonstrated to reduce the risk 
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of cardiac events and improved cardiac 
function in experimental and clinical stud-
ies (Nityanand et al., 1989; Sheela and Au-
gusti, 1995; Gaur et al., 1997; Szapary et 
al., 2003; Ulbricht et al., 2005). The protec-
tive action of guggulsterone is due to anti-
oxidant property because it inhibits the gen-
eration of oxygen free radicals (Chander et 
al., 2002). Guggulsterone was also reported 
to have protection against oxidative modifi-
cations of lipid and protein components of 
LDL induced by Cu2+ in vitro (Singh et al., 
1977). A standard alcoholic fraction from 
guggulipid containing E-guggulsterone was 
already studied and proved for its protection 
against free radical damage in the skin and 
scavenging of superoxide anions and hy-
droxyl radicals in non-enzymatic test sys-
tems (McCord and Fridovich, 1969). Stud-
ies of Saxena et al. (2007) demonstrated 
that the protective effect of gugulipid iso-
lated from Commmiphora whighitii against 
STZ-induced memory deficits model of 
dementia in mice was due to antioxidant 
potential. Thus, the antioxidant potential of 
C. mukul observed in the present study may 




The results from the present study sug-
gest that C. mukul provides significant pro-
tection to brain against the consequence of 
hyperglycemia and diabetes induced oxida-
tive stress by scavenging reactive oxygen 
species and blocking free radical interac-
tions. Thus, C. mukul may be potentially 
beneficial in prevention of diabetic induced 
neuropathy. The beneficial effects of C. 
mukul on brain oxidative stress is important 
in view of the evidences linking increased 
oxidative stress to a number of neurodegen-
erative diseases like Parkinson’s disease, 
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